Cas:46814-61-3 N’-[2-(dimethylamino)ethyl]-N,N-dimethyl-N’-phenylethane-1,2-diamine manufacturer & supplier

We serve Chemical Name:N’-[2-(dimethylamino)ethyl]-N,N-dimethyl-N’-phenylethane-1,2-diamine CAS:46814-61-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N'-[2-(dimethylamino)ethyl]-N,N-dimethyl-N'-phenylethane-1,2-diamine

Chemical Name:N’-[2-(dimethylamino)ethyl]-N,N-dimethyl-N’-phenylethane-1,2-diamine
CAS.NO:46814-61-3
Synonyms:1,1,7,7-tetramethyl-4-phenyl diethylene triamine;einecs 256-280-1
Molecular Formula:C14H25N3
Molecular Weight:235.36800
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:320.8ºC at 760 mmHg
Density:0.976g/cm3
Index of Refraction:1.541
PSA:9.72000
Exact Mass:235.20500
LogP:1.61620

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1,1,7,7-tetramethyl-4-phenyl diethylene triamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,einecs 256-280-1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,einecs 256-280-1 Use and application,1,1,7,7-tetramethyl-4-phenyl diethylene triamine technical grade,usp/ep/jp grade.


Related News: These include: high-barrier generic drug substances and commonly used generic drug substances. N’-[2-(dimethylamino)ethyl]-N,N-dimethyl-N’-phenylethane-1,2-diamine manufacturer In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. N’-[2-(dimethylamino)ethyl]-N,N-dimethyl-N’-phenylethane-1,2-diamine supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. N’-[2-(dimethylamino)ethyl]-N,N-dimethyl-N’-phenylethane-1,2-diamine vendor These include: high-barrier generic drug substances and commonly used generic drug substances. N’-[2-(dimethylamino)ethyl]-N,N-dimethyl-N’-phenylethane-1,2-diamine factory First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s.